Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-Label Phase II Study of Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

NCT00337506 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT00337506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00337506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-Label Phase II Study of Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2003
Completion date
Not reported
Enrollment
50
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma